semaglutide (NPM-139) — Topline data
Nov 2026
We currently anticipate topline data for the trial will be available in November, 2026.Source filing
VANI biotech catalysts & pipeline
VIVANI MEDICAL INC · Data as of 2026-09-08
Upcoming catalysts
semaglutide (NPM-139) — IND submission
2027
Preparation, and submission of an Investigational New Drug ("IND") Application for NPM-139 to support initiation of a proposed Phase 2 dose-ranging study of this semaglutide implant planned for 2027.Source filing